"Can i ask what good interim results are we looking for that will give the FDA reasons for stopping the trial earlier"
Confirmation Phase 2 trial results would be enough IMO:
"All of the HF-MACE seen over 36 months in the Phase 2 trial occurred in control patients................with an overall 71% HF-MACE rate over 36 months. In contrast, no HF-MACE were seen over the entire 36 months in 150 million MPC-treated patients...........p=0.0007 "
Interesting to note that SI has stated (in one of the videos) that a the phase 2 group follow up showed this trend continuing hence the alteration of the primary end points.
my emphases
"Can i ask what good interim results are we looking for that...
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.51 |
Change
0.020(1.34%) |
Mkt cap ! $1.724B | |||
| Open | High | Low | Value | Volume |
| $1.57 | $1.58 | $1.41 | $18.15M | 12.09M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3418 | $1.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.51 | 24361 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |